Stocks · US
BSX
XNYS
Boston Scientific Corp.
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E16.72x
P/B2.46x
P/S2.93x
EPS$2.54
ROE14.74%
ROA8.13%
Dividend yield0.00%
EV/EBITDA12.33x
Debt/Equity0.51
Free cash flow$3.6B
Returns and 52-week range
1W-3.85%
1M-11.74%
3M-5.85%
6M-31.80%
1Y-56.65%
YTD-55.45%
52W high$105.65
52W low$41.94
From 52W high-60.07%
Company
HeadquartersMarlborough, MA
Employees59,000
Listed1992-05-18
Websitewww.bostonscientific.com
SECFilings
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| The Cigna Group | $71.7B | 11.17 | 1.68 | -2.88% |
| Natera, Inc. Common Stock | $61.4B | — | 33.68 | +22.08% |
| 리제네론 파머슈티컬스 | $74.8B | 17.28 | 2.36 | -10.75% |
| Cencora, Inc. | $60.1B | 22.90 | 19.70 | -4.41% |
| 모더나 | $81.1B | — | 12.00 | +28.79% |
| Cardinal Health, Inc. | $54.0B | 31.49 | — | -5.56% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.